Pharmaceutical Supply – Albuterol Sulfate Inhalation Aerosol

The contract calls for the supply of albuterol sulfate inhalation aerosol in 8.5g canisters, each containing 200 actuations with 108 mcg per actuation, adhering to strict military and medical packaging standards to ensure safety, stability, and compatibility with federal healthcare systems. The product must meet all regulatory and performance requirements for use in defense and military medical environments, with packaging designed to withstand deployment, storage, and field conditions without compromising efficacy or sterility. The contract is structured as a subcontract under the NAICS code 325412, which classifies it within pharmaceutical and medicine manufacturing. The solicitation was posted on July 27, 2026, with a response deadline of August 3, 2026, and the place of performance is identified as Fort Bragg, North Carolina, with a ZIP code of 28310. The contracting organization is the Medical Supply Chain Pharm FSA under the Department of Defense, emphasizing the direct alignment with military health operations. This procurement is part of a broader effort to maintain a reliable and compliant pharmacological supply chain for respiratory emergency care within military installations, ensuring that service members and authorized personnel have uninterrupted access to essential medications.